Independent Antibodies: Western Blot: EPLIN Antibody [NBP1-87947] - Analysis using Anti-LIMA1 antibody NBP1-87947 (A) shows similar pattern to independent antibody NBP2-38673 (B).
Immunocytochemistry/ Immunofluorescence: EPLIN Antibody [NBP1-87947] - Staining of human cell line U-2 OS shows localization to plasma membrane, cytosol and actin filaments. Antibody staining is shown in green.
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human pancreas using Anti-LIMA1 antibody NBP1-87947.
Orthogonal Strategies: Western Blot: EPLIN Antibody [NBP1-87947] - Analysis in human cell lines A-431 and A-549. Corresponding RNA-seq data are presented for the same cell lines. Loading control: Anti-PPIB.
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human rectum shows high expression.
Orthogonal Strategies: Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining in human rectum and pancreas tissues using anti-LIMA1 antibody. Corresponding LIMA1 RNA-seq data are presented for the ...read more
Independent Antibodies: Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human liver, pancreas, rectum and testis using Anti-LIMA1 antibody NBP1-87947 (A) shows similar protein ...read more
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human testis.
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human liver.
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human rectum.
Immunohistochemistry-Paraffin: EPLIN Antibody [NBP1-87947] - Staining of human rectum using Anti-LIMA1 antibody NBP1-87947.
This antibody was developed against Recombinant Protein corresponding to amino acids: ISENSYSLDDLEIGPGQLSSSTFDSEKNESRRNLELPRLSETSIKDRMAKYQAAVSKQSSSTNYTNELKASGGEIKIHKMEQKENVPPGPEVCITHQEGEKISANENSLAVRSTPAEDDSRDS
Specificity of human EPLIN antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
Immunogen affinity purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
IHC-P reported in scientific literature (PMID: 24135282). For IHC-Paraffin, HIER pH 6 retrieval method is recommended. ICC/IF Fixation Permeabilization: Use PFA/Triton X-100.
85 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Mouse reactivity reported in the scientific literature (PMID: 24135282).
Packaging, Storage & Formulations
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
PBS (pH 7.2) and 40% Glycerol
0.02% Sodium Azide
Immunogen affinity purified
Alternate Names for EPLIN Antibody
Epithelial protein lost in neoplasm
EPLINepithelial protein lost in neoplasm beta
LIM domain and actin binding 1
SREBP3LIM domain and actin-binding protein 1
sterol regulatory element binding protein 3
This gene encodes a cytoskeleton-associated protein that inhibits actin filament depolymerization and cross-links filaments in bundles. It is downregulated in some cancer cell lines. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and expression of some of the variants maybe independently regulated. [provided by RefSeq, Aug 2011]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our EPLIN Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.